Bristol Will Buy Diabetes Drug Maker

Bristol-Myers Squibb said it will buy diabetes drug maker Amylin in a $7 billion deal that will intensify the competition to treat the growing number of people afflicted with the disease.

  • How Do Healthcare Companies Market Their Products? - Motley Fool
    In many cases, they buy doctors ... of the big dog in diabetes, if they launched a new diabetes drug, they ... Johnson , Pfizer,  Bristol-Myers
    07/19/2016 - 9:04 am | View Link
  • Old pharma sees new profit cure in cancer drugs -
    DEALTALK-Old pharma sees new profit cure in cancer drugs - Reuters UK
    07/19/2016 - 7:48 am | View Link
  • More
  • AstraZeneca to Buy Bristol’s Stake in Diabetes Joint Venture
    AstraZeneca (AZN) agreed on Thursday to buy Bristol-Myers Squibb’s ... an advisory panel recommended that the U.S. Food and Drug Administration approve dapagliflozin, an experimental treatment for Type 2 diabetes. A similar treatment from Johnson ...
    12/19/2013 - 8:03 pm | View Link
  • AstraZeneca to buy Bristol out of diabetes venture for up to $4.1 billion
    The move will bulk up AstraZeneca's thin drug portfolio and give Bristol ... Speculation that AstraZeneca might look to buy out Bristol was fuelled last month when the U.S.-based company decided to get out of diabetes research. The decision to quit ...
    12/18/2013 - 8:39 pm | View Link
  • Bristol-Myers Squibb: Buy Before Eliquis Entry In 2013
    Bristol-Myers Squibb (BMY) has been in the news for a number of positive reasons. The company recently announced it will buy Amylin, a diabetes drug manufacturer, for $5.3 billion dollars. Many analysts are deeming the acquisition an excellent fit ...
    07/4/2012 - 5:18 am | View Link
  • Bristol-Myers to buy diabetes drug maker for $5 billion
    Bristol-Myers Squibb Co. said it plans to buy diabetes drug maker Amylin Pharmaceuticals for about $5 billion in cash. Bristol-Myers will enter an agreement with British drug maker AstraZeneca to develop and commercialize Amylin's diabetes drugs, the ...
    07/1/2012 - 7:04 pm | View Link
  • Bristol-Myers Squibb Co. agrees to buy diabetes drugmaker
    NEW YORK — Bristol-Myers Squibb Co. agreed to buy diabetes drugmaker Amylin Pharmaceuticals for about $5 billion in cash, heating up the competition among drug producers to develop diabetes treatments. After the deal is complete, Bristol-Myers will enter ...
    07/1/2012 - 10:26 am | View Link
  • More
  • Cafepharma | Home
    Biogen CEO George Scangos to step down, potential future biotech buyouts, Galenica to buy Relypsa, and more - scroll down for the latest news
    07/22/2016 - 12:42 pm | View Website
  • Bristol-Myers Squibb | FiercePharma
    BMS CEO Lamberto Andreotti 15. Bristol-Myers Squibb ($BMY) 2014 revenue: $15.879 billion 2013 revenue: $16.385 billion Over the past several years, as its Big Pharma ...
    07/22/2016 - 10:40 am | View Website
  • Generic Drugs
    Glucophage, for example, is Bristol-Myers Squibb’s brand of the drug whose generic name is metformin. For years, Glucophage was the only brand of metformin on the U ...
    07/22/2016 - 7:55 am | View Website
  • Metformin
    Metformin, marketed under the tradename Glucophage among others, is the first-line medication for the treatment of type 2 diabetes. This is particularly true in ...
    07/21/2016 - 11:27 pm | View Website
  • My Mexican Drug Store
    MyMexicanDrugStore enables you to purchase quality medicines from Mexico at prices that are typically 70% to 90% less than in the United States. MyMexicanDrugStore is ...
    07/21/2016 - 8:43 pm | View Website
  • More
Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More News